184 related articles for article (PubMed ID: 29903629)
1. Magnetic resonance imaging in dementia.
Raposo Rodríguez L; Tovar Salazar DJ; Fernández García N; Pastor Hernández L; Fernández Guinea Ó
Radiologia (Engl Ed); 2018; 60(6):476-484. PubMed ID: 29903629
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
Nikolaus S; Antke C; Müller HW
Behav Brain Res; 2009 Dec; 204(1):1-31. PubMed ID: 19523490
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging in dementia.
Tartaglia MC; Rosen HJ; Miller BL
Neurotherapeutics; 2011 Jan; 8(1):82-92. PubMed ID: 21274688
[TBL] [Abstract][Full Text] [Related]
4. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
[TBL] [Abstract][Full Text] [Related]
5. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.
Snowden JS; Thompson JC; Stopford CL; Richardson AM; Gerhard A; Neary D; Mann DM
Brain; 2011 Sep; 134(Pt 9):2478-92. PubMed ID: 21840888
[TBL] [Abstract][Full Text] [Related]
6. Parkinson-related dementias.
Boeve BF
Neurol Clin; 2007 Aug; 25(3):761-81, vii. PubMed ID: 17659189
[TBL] [Abstract][Full Text] [Related]
7. [Morphological magnetic resonance imaging: its value for the diagnosis of neurodegenerative diseases].
Hahn U; Schwarz J; Gratz S; Kaiser JW; Jarnig M; Förstl H
Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S15-8. PubMed ID: 18437637
[TBL] [Abstract][Full Text] [Related]
8. Rates of cerebral atrophy differ in different degenerative pathologies.
Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
King AE; Mintz J; Royall DR
Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
[TBL] [Abstract][Full Text] [Related]
10. Dementia spectrum disorders: lessons learnt from decades with PET research.
Wilson H; Pagano G; Politis M
J Neural Transm (Vienna); 2019 Mar; 126(3):233-251. PubMed ID: 30762136
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease.
Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Hayashi T; Oyanagi C; Konishi J; Shio H
J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):623-9. PubMed ID: 11032614
[TBL] [Abstract][Full Text] [Related]
12. Differentiating the dementias. Revisiting synucleinopathies and tauopathies.
Hickey C; Chisholm T; Passmore MJ; O'Brien JD; Johnston J
Curr Alzheimer Res; 2008 Feb; 5(1):52-60. PubMed ID: 18288932
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
14. Neuroimaging in dementia.
Vitali P; Migliaccio R; Agosta F; Rosen HJ; Geschwind MD
Semin Neurol; 2008 Sep; 28(4):467-83. PubMed ID: 18843575
[TBL] [Abstract][Full Text] [Related]
15. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
[TBL] [Abstract][Full Text] [Related]
16. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
[TBL] [Abstract][Full Text] [Related]
17. An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies.
Kasahata N; Hagiwara M; Kato H; Nakamura A; Uchihara T
J Alzheimers Dis; 2014; 39(3):471-6. PubMed ID: 24217279
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
[TBL] [Abstract][Full Text] [Related]
19. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
Meyer JS; Huang J; Chowdhury MH
J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
[TBL] [Abstract][Full Text] [Related]
20. [Is hippocampal atrophy a specific change for Alzheimer's disease?].
Hanyu H; Asano T; Sakamoto S; Kogure D; Iwamoto T; Takasaki M
No To Shinkei; 1999 Nov; 51(11):947-51. PubMed ID: 10586410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
